Ofloxacin – topical administration in the eye/ear
Generic name
Ofloxacin – topical administration in the eye/ear
Brand name
ATC Code
S01AE01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
After administration in the ear, serum concentrations are very low to undetectable [Okyama 1999].
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Eye infection, broad spectrum |
|---|
|
| Chronic suppurative middle ear inflammation with perforated eardrum, middle ear inflammation with tubes, external ear inflammation |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
When applied to the eye: burning sensation, photophobia, reduced vision
When applied to the ear: bitter taste, dizziness, dry mouth, itching, vertigo, ear pain, paraesthesia, tinnitus. No effects on hearing.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
In general, children´s eyes show a stronger response to irritations than the adults´ eyes. Irritations can affect the compliance of children. [SmPC Floxal® 3 mg/ml eye drops (GER)]
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIINFECTIVES
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Antibiotics | ||
|---|---|---|
| S01AA26 | ||
| S01AA11 | ||
| S01AA24 | ||
| S01AA12 | ||
| Antivirals | ||
|---|---|---|
| S01AD03 | ||
| ANTIBIOTICS | ||
|---|---|---|
| S01AA26 | ||
| S01AA11 | ||
| S01AA24 | ||
| S01AA12 | ||
| ANTIVIRALS | ||
|---|---|---|
| S01AD03 | ||
| Fluoroquinolones | ||
|---|---|---|
| S01AE07 | ||
References
- Constantinou M, et al, Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial, Ophthalmology, 2007 , Sep;114(9), 1622-9
- Schwartz RH., Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients , Curr Med Res Opin, 2006, Sep;22(9), 1725-36
- Torum B, et al , Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial., Clin Ther, 2004, Jul;26(7), 1046-54
- Roland PS, et al, Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes, Pediatrics, 2004, Jan;113(1 Pt 1), e40-6
- Lichtenstein SJ, et al, Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients, J AAPOS, 2003, Oct;7(5), 317-24
- Schwab IR, et al , A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis, Ophthalmology, 2003, Mar;110(3), 457-65
- Goldblatt EL. , Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes, Pediatr Infect Dis J. , 2001 , Jan;20(1), 116-9; discussion 120-2
- Bluestone CD, Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children, Pediatr Infect Dis J, 2001, Jan;20(1), 111-5; discussion 120-2
- Tabbara KF, et al, Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%, Eur J Ophthalmol, 1999, Oct-Dec;9(4), 269-75
- Dohar JE, et al, Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes, Arch Otolaryngol Head Neck Surg, 1999, May;125(5), 537-45
- Ohyama M, et al, Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations, Arch Otolaryngol Head Neck Surg, 1999, Mar;125(3), 337-40
- Goldblatt EL, et al, Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes, Int J Pediatr Otorhinolaryngol, 1998, Nov 15;46(1-2), 91-101
- Agro AS, et al, Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media, Clin Ther., 1998, Jul-Aug;20(4), 744-59
- Kaga K, et al, A preliminary report: clinical effects of otic solution of ofloxacin in infantile myringitis and chronic otitis media, Int J Pediatr Otorhinolaryngol., 1998, Jan;42(3), 199-205
- Jones RN, et al, Ofloxacin otic solution for treatment of otitis externa in children and adults, Arch Otolaryngol Head Neck Surg, 1997, Nov;123(11), 1193-200
Changes
Therapeutic Drug Monitoring
Overdose
